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ABSTRACT
Background: CD14 is an essential component of the receptor for lipopolysaccharide (LPS) . LPS stimulates
T-helper type 1 (Th1) cytokine expression, potentially suppressing Th2 immune responses involved in IgE-
mediated allergic diseases. Previous studies have reported that -159CT, a promoter polymorphism of CD14,
is associated with total serum IgE levels and atopy, but other studies have shown conflicting results.
Methods: To examine possible associations of CD14 polymorphisms with asthma susceptibility , we per-
formed transmission disequilibrium tests (TDTs) of 137 Japanese families identified through children with
atopic asthma．
Results: We found no association between -159CT polymorphism and asthma (p= 0.37) . Quantitative TDT
and ANOVA showed no association between the -159CT genotype and total serum IgE levels. We also per-
formed a meta-analysis of data from all available studies. Neither a fixed-effects model nor a random-effect
model showed a significant odds ratio for the -159CT polymorphism (p > 0.1).
Conclusions: Our data indicate that CD14 does not contribute substantially to susceptibility to asthma. Fur-
ther studies examining both genotypes and environmental factors will be necessary to elucidate the role of
CD14 in the development of allergic diseases.
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INTRODUCTION
Allergic diseases such as asthma, atopic dermatitis,
and allergic rhinitis, are growing major public health
issues. Asthma affects nearly 155 million individuals
worldwide.1 Although environmental factors are im-
portant, there are strong genetic predispositions for
the development of allergic diseases．
Several linkage studies have provided evidence for
association of asthma andor related traits with chro-
mosome region 5q31.2-4 There are many candidate
genes clustered in this region including interleukin
(IL)4,IL5,granulocyte-macrophage colony-stimulating
factor ( GMCSF ), IL9, IL13 and CD14.
The hygiene hypothesis, introduced by Strachan,5
suggests that improved hygiene conditions in recent
years have changed the type and level of stimulation
from the microbial environment and that this may in-
directly influence postnatal development of the im-
mune system, leading to increased predisposition to
allergic diseases in childhood. Natural immunity to
some bacterial and viral infections induces a T-helper
type 1 (Th1) pattern of cytokine release, potentially
suppressing Th2 immune responses involved in IgE-
mediated allergic diseases. Lipopolysaccharide (LPS)
is a major component of the bacterial cell wall and is
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known to stimulate production of IL12, a Th1-type cy-
tokine, by antigen-presenting cells.6 CD14 is an es-
sential component of the receptor for LPS,7 and is ex-
pressed on the cell surface of monocytes , macro-
phages and neutrophils. CD14 has two protein forms:
a glycosylphosphatidylinositol-anchored membrane
protein form (mCD14 ) and a monocyte- or liver-
derived soluble serum protein form (sCD14). Both
mCD14 and sCD14 are critical for LPS-dependent sig-
nal transduction and inflammatory processes . Re-
cently , several polymorphisms in CD14 have been
identified in both the coding and promoter regions.
One of the polymorphisms, a C to T transition at posi-
tion -159 (-159CT), has been investigated as a candi-
date in asthma and allergic diseases. Gel-shift assay
revealed that the T allele of -159CT has a decreased
affinity for DNAprotein interactions with SP1, SP2
and SP3 transcription factors.8 While the -159CT
polymorphism is reported to be associated with ele-
vated levels of sCD14 in serum and with total serum
IgE levels9 and atopy,10 other reports have shown
conflicting results.11-13
The aim of this study was to investigate whether
the -159CT polymorphism is associated with asthma
in a Japanese population. To increase the sample size
and power, we performed meta-analysis of all avail-
able studies and examined possible associations be-
tween asthma susceptibility and CD14 polymor-
phisms.
METHODS
SUBJECTS
Probands of the families studied were asthmatic chil-
dren treated at the Pediatric Allergy Clinic of the Uni-
versity Hospital of Tsukuba (Japan). A full verbal and
written explanation of the study was given to all fam-
ily members interviewed, and 137 families (466 mem-
bers) gave informed consent and participated in this
study. Informed consent for subjects younger than
school age was provided by their parents . All the
families had two parents and at least one proband.
This study was approved by the Committee of Ethics
of the University of Tsukuba．
Each family member was questioned regarding al-
lergic symptoms and underwent a physical examina-
tion by a pediatrician. Asthma was diagnosed accord-
ing to the criteria established by the National Insti-
tutes of Health (USA) with minor modifications (Na-
tional Heart Blood and Lung Institute, 1995). Criteria
included the following: two or more episodes of
wheezing and shortness of breath during the past
year and reversibility of the wheezing and dyspnea,
either spontaneously or by bronchodilator treatment.
Patients treated with systemic steroids were ex-
cluded from this study. Because wheezing is often as-
sociated with viral respiratory infection in young chil-
dren, only subjects older than 3 years of age were
evaluated for the asthma phenotype．
GENOTYPING AND TRANSMISSION DISE-
QUILIBRIUM TESTS (TDT)
Genomic DNA was extracted from peripheral blood
leukocytes. The regions of interest were amplified by
PCR with primers 5 ’ -GGTTGGATAGTGCAGAGT-3 ’
and 5 ’ -CCCTGATCACCTCCCAC-3 ’ . The expected
PCR product size was 263 bp. Amplified PCR prod-
ucts were subjected to AvaII digestion . Expected
product sizes for the T allele were 79 bp and 184 bp,
and expected product size for the C allele was 263 bp.
Digested products were run on 2% agarose gels.
Family-based association tests were performed
with a TDT as implemented by the ASPEX Program
(http：aspex.sourceforge.net). Quantitative TDT
tests of total serum IgE levels were performed with
the QTDT program.14
META-ANALYSIS
We performed computer-based searches (National Li-
brary of Medicine, MEDLINE) and hand searches of
relevant journals to identify studies published prior to
March 2005 that were related to asthma and CD14.
For the electronic searches, we used a combination
of key words related to CD14 and asthma . We in-
cluded articles published in any languages. To be eli-
gible for inclusion in the present study, studies had to
meet all of the following criteria : design , case-
controlled trials ; subjects , patients with asthma ;
method, genotype of CD14 -159CT polymorphism;
and results, genotype and allele data . We included
our data in the meta-analysis. Control alleles in the
present study referred to an artificially constructed
control population consisting of non-transmitted pa-
rental alleles as described by Kirov et al.15
Meta-analysis was performed with the Mantel-
Haenszel method as a fixed-effects model test and the
DerSimonian-Laird method as a random-effects
model test. Heterogeneity among studies was tested
by the χ2 statistic obtained by adding the weighted
squares of the deviation of each estimate from the
pooled estimate. Publication bias was examined by
funnel plot of the reported effect assessed with the
odds ratio against the standard error of the natural
logarithm of the odds ratio (p > 0.10). We estimated
odds ratios by comparing asthmatic cases with con-
trols in the same study and calculated odds ratios un-
der the hypothesis that individuals possessing the
-159C allele were more susceptible to asthma．
RESULTS
Frequencies of the -159 CC, CT, and TT genotypes in
parents were 21, 55 and 24%, respectively. Allele fre-
quency for T was estimated at 52%, and the distribu-
tion did not deviate from the expected Hardy-
Weinberg equilibrium (p = 0.09)．
Preferential transmission of either the -159C or
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Fig. 1 Meta-analysis of 10 published studies of CD14 polymorphism and asthma
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-159T allele was not observed by TDT analysis (trans-
mitted 121 versus not transmitted 108 for -159C, p =
0.37). Mean log [total serum IgE] levels of parents
with the CC, CT and TT genotypes were 1.99, 1.99
and 2.05, respectively; no significant association was
observed between groups (p = 0.83 for ANOVA). By
quantitative TDT analysis, no associations were ob-
served between log [ total serum IgE ] levels and
either allele of the -159CT polymorphism (p = 0.19)．
The total number of subjects included in the meta-
analysis was 2199 patients with asthma and 1973 con-
trol individuals ( Fig. 1 )．10-13, 16-20 No publication bias
was observed by funnel plot of the reported effects of
-159CT (p = 0.67). Overall, the combined odds ratio
of the fixed-effects model for asthma with -159C was
1.0053 (95% confidence interval (CI), 0.92 to 1.096; p =
0.92; test of homogeneity, Q = 15.61, df = 10, p = 0.11).
The odds ratio of the random effects model for -159C
was 1.017 (95% CI 0.91 to 1.14; p = 0.77)．
DISCUSSION
The TDT analysis in the present study showed no as-
sociation between CD14 -159CT polymorphism and
asthma or total serum IgE levels. Conflicting results
are often observed in studies of the genetics of com-
plex traits. Some studies show associations between a
polymorphism and a disease, whereas others fail to
replicate the results. Discrepancies may be due to dif-
ferences in the populations studied, difficulty in defin-
ing the phenotypes, or lack of statistical power. We
performed a meta-analysis to increase the power of
the analysis of asthma and the CD14−159CT poly-
morphism . However , we found no association of
asthma and the -159CT polymorphism．
There are several potential limitations of our meta-
analysis. First, meta-analyses are limited by the num-
bers of studies included. Traditionally, meta-analyses
are most powerful when large numbers of studies are
included. It is possible that the influence of the
CD14-159CT polymorphism for susceptibility to
asthma is quite small. The meta-analysis performed
in the present study had the power (β= 0.8) to detect
significant odds ratios as low as 1.19. However, this
may not be enough to identify modest genetic effects
in common diseases such as asthma．
Regulation of CD14 expression appears to be im-
portant in diseases such as gram-negative septic
shock,21 HIV infection22 and malaria.23 The func-
tional -159CT polymorphism of CD14 has been
studied extensively in relation to various diseases and
has been shown to be associated with coronary artery
complications in Kawasaki disease , 24 and in IgA
nephropathy.25 The -159CT polymorphism is also
associated with serum sCD14 levels , with subjects
with the TT genotype showing the highest levels of
sCD14.13,26 Both TDT and meta-analysis in the pre-
sent study failed to show involvement of the -159CT
polymorphism in the development of asthma . Be-
cause CD14 expression in blood cells is influenced by
exposure levels,27 differences in endotoxin load may
contribute to individual disease susceptibility. In de-
veloped countries , endotoxin levels in the environ-
ment are very low, so there is the possibility of failing
to show involvement of the -159CT polymorphism in
the development of asthma. However, the endotoxin
switch hypothesis proposed by Vercelli 28 suggests
that exposure to certain antigen concentrations may
result in opposite responses, depending on the envi-
ronmental context. According to this hypothesis, the
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Th cytokine profile would not differ in response to
very low or very high endotoxin exposure, regardless
of genotype, but the -159CT polymorphism may ef-
fect different Th cytokine responses in response to in-
termediate levels of exposure. Further studies exam-
ining both environmental endotoxin exposure and
CD14 genotypes will be necessary to elucidate the
role of CD14 in allergic diseases．
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